{"date":"2026-10-01","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-10-01-2112-sh7fjn","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"21:12:13","subject":"代重要子公司Belite Bio, Inc公告受邀參加創新視網膜研討會(Innovate Retina Conference)","clause":"第44款","fact_date":"2026-10-09","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-10-01 21:12，「代重要子公司Belite Bio, Inc公告受邀參加創新視網膜研討會(Innovate Retina Conferen」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-10-01-2109-1e7ske3","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"21:09:25","subject":"代重要子公司Belite Bio, Inc公告受邀參加美國眼科學會2026年會(AAO 2026)","clause":"第44款","fact_date":"2026-10-11","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-10-01 21:09，「代重要子公司Belite Bio, Inc公告受邀參加美國眼科學會2026年會(AAO 2026)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-10-01-1834-1gbbesv","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"18:34:55","subject":"公告本公司今日接獲註冊代理人通知，阿爾及利亞ANPP受理Bonvadis外用乳膏完全傷口適應症產品註冊申請。","clause":"第10款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-10-01 18:34，「公告本公司今日接獲註冊代理人通知，阿爾及利亞ANPP受理Bonvadis外用乳膏完全傷口適應症產品註冊申請。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-10-01-1813-6mtof5","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"18:13:17","subject":"本公司異體幹細胞獲得衛生福利部外銷專用藥品許可證","clause":"第51款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-10-01 18:13，「本公司異體幹細胞獲得衛生福利部外銷專用藥品許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-10-01-1809-d8t9b","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"18:09:51","subject":"公告本公司董事會決議召開115年第二次股東臨時會相關事宜","clause":"第32款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-10-01 18:09，「公告本公司董事會決議召開115年第二次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-10-01-1759-1gy0und","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"17:59:55","subject":"代重要子公司SUNETIC BIOTECH INC.公告新任董事長","clause":"第6款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-10-01 17:59，「代重要子公司SUNETIC BIOTECH INC.公告新任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-10-01-1748-1ql5u6r","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"17:48:31","subject":"公告本公司開發之異體臍帶間質幹細胞治療慢性阻塞性肺病製劑產品麥力優取得衛福部核發外銷專用藥品許可證。","clause":"第44款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-10-01 17:48，「公告本公司開發之異體臍帶間質幹細胞治療慢性阻塞性肺病製劑產品麥力優取得衛福部核發外銷專用藥品許可證。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-10-01-1741-q9aep9","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"17:41:07","subject":"代子公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款公告背書保證事項","clause":"第22款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-10-01 17:41，「代子公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款公告背書保證事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-10-01-1738-1aaf7mb","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"17:38:59","subject":"公告本公司限制員工權利新股第一次發行之增資基準日","clause":"第53款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-10-01 17:38，「公告本公司限制員工權利新股第一次發行之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-10-01-1639-1fweyex","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"16:39:11","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告董事當選名單","clause":"第6款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-10-01 16:39，「代重要子公司Alvogen Korea Holdings Ltd.公告董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-10-01-1638-ifbkml","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"16:38:56","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告2026年股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-10-01 16:38，「代重要子公司Alvogen Korea Holdings Ltd.公告2026年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-10-01-1631-jc1x6d","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"16:31:20","subject":"公告本公司新藥PS1用於第二型糖尿病之美國二期臨床試驗 (IND)申請，今日已完成美國FDA送件。","clause":"第8款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-10-01 16:31，「公告本公司新藥PS1用於第二型糖尿病之美國二期臨床試驗 (IND)申請，今日已完成美國FDA送件。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-10-01-1624-1kqz2hq","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"16:24:13","subject":"公告本公司115年現金增資發行新股案申請調整每股發行價格經金管會同意備查","clause":"第44款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-10-01 16:24，「公告本公司115年現金增資發行新股案申請調整每股發行價格經金管會同意備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-10-01-1555-1r5m7ka","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"15:55:44","subject":"代重要子公司台灣味群工業股份有限公司公告115年第一次現金增資全體董事放棄認購股數達認購股數二分之一以上，並洽特定人認購相關事宜","clause":"第45款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-10-01 15:55，「代重要子公司台灣味群工業股份有限公司公告115年第一次現金增資全體董事放棄認購股數達認購股數二分之一以上，並洽特定人認購」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-10-01-1555-y1d8tg","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"15:55:21","subject":"代重要子公司台灣味群工業股份有限公司公告辦理115年第一次現金增資發行新股相關事宜—修改事項","clause":"第11款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-10-01 15:55，「代重要子公司台灣味群工業股份有限公司公告辦理115年第一次現金增資發行新股相關事宜—修改事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-10-01-1554-74672","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"15:54:20","subject":"本公司受邀參加富邦綜合證券舉辦之法人說明會(更正說明會開始時間)","clause":"第30款","fact_date":"2026-10-15","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-10-01 15:54，「本公司受邀參加富邦綜合證券舉辦之法人說明會(更正說明會開始時間)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2026-10-01-1549-1bkm0mx","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"15:49:41","subject":"公告本公司代理發言人異動","clause":"第11款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2026-10-01 15:49，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-10-01-1503-m3t854","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-10-01","time":"15:03:36","subject":"本公司受邀參加富邦綜合證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-10-15","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-10-01 15:03，「本公司受邀參加富邦綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-10-01-1501-zl9grk","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"15:01:47","subject":"公告本公司法人董事改派代表人。","clause":"第6款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-10-01 15:01，「公告本公司法人董事改派代表人。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2026-10-01-1433-15yhvdj","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2026-10-01","time":"14:33:04","subject":"公告本公司法人董事改派法人代表人","clause":"第6款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2026-10-01 14:33，「公告本公司法人董事改派法人代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-10-01-1401-1xvq80b","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"14:01:42","subject":"代子公司Changsung Softgel System Ltd公告法人董事、監察人發生異動，暨董事異動達三分之一(誤植更正)(更正115年7月23日公告之新任者簡歷)","clause":"第6款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-10-01 14:01，「代子公司Changsung Softgel System Ltd公告法人董事、監察人發生異動，暨董事異動達三分之一(誤植」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-10-01-1334-100esni","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-10-01","time":"13:34:34","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2026-10-01","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-10-01 13:34，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}